Finished
Local Control After Robot-assisted Supraglottic Laryngectomy
NCT03357107 · Hospices Civils de Lyon · Updated 30 Nov 2017
- What is being tested
- Transoral robotic surgery (TORS)
- For
- Supraglottic Squamous Cell Carcinoma
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 122 people. The full rules are on the registry page.
- Where
- France
- When
- Starts or started 1 Oct 2016, ends 28 Feb 2017. Registered 29 Nov 2017.
- Results
- None posted yet.
In the researchers' words
Transoral robotic surgery is an option to treat supraglottic squamous cell carcinomas. Oncological outcomes 2 years after transoral robotic surgery for supraglottic laryngectomy were studied.
Sites
- Croix-Rousse Hospital, Hospices Civils de LyonLyon, France